Dolby Laboratories (DLB)

Dolby Laboratories has shown strong liquidity positions over the past five years, as indicated by its current ratio, quick ratio, and cash ratio. The current ratio measures the company's ability to cover its short-term liabilities with its current assets. Dolby's current ratio decreased from 5.79 in 2020 to 3.52 in 2023 but remained above 1, which suggests that the company has more than enough current assets to meet its short-term obligations.

The quick ratio, which provides a more stringent measure of liquidity by excluding inventory from current assets, also demonstrated a decreasing trend from 5.10 in 2020 to 3.07 in 2023. However, similar to the current ratio, the quick ratio values remained well above 1, indicating Dolby's strong ability to cover its short-term liabilities using its most liquid assets.

Furthermore, the cash ratio, the most conservative measure of liquidity, considers only cash and cash equivalents to cover current liabilities. Dolby's cash ratio decreased from 4.19 in 2020 to 2.09 in 2023, indicating a slight reduction in the company's ability to pay off its short-term obligations using cash alone. However, the cash ratio values remained relatively high, indicating that the company still has sufficient liquid resources to meet its immediate obligations.

Overall, Dolby Laboratories has maintained a healthy liquidity position over the years, with current, quick, and cash ratios consistently above industry benchmarks. Despite some fluctuations in the ratios over time, the company appears to have a strong ability to meet its short-term financial commitments.

---

Additional liquidity measure

Dolby Laboratories' cash conversion cycle, representing the time it takes for the company to convert its investments in inventory and other resources into cash, has exhibited fluctuating trends over the past five years. In Sep 2023, the cash conversion cycle increased to 151.04 days compared to 126.25 days in Sep 2022. This signifies that Dolby Laboratories took longer to convert its investments into cash during the most recent period.

In comparison to Sep 30, 2021, where the cash conversion cycle was 74.91 days, the recent increase can be seen as a significant shift. This suggests that Dolby Laboratories may be experiencing challenges in efficiently managing its working capital and turning its investments into cash within a reasonable timeframe.

It is essential for the management of Dolby Laboratories to closely monitor and address the factors contributing to this extended cash conversion cycle to ensure optimal utilization of resources and maintain healthy liquidity levels. By implementing strategies to streamline operations, improve inventory management, and enhance collection processes, Dolby Laboratories can potentially shorten its cash conversion cycle and improve its overall financial performance.